E. Goeser, M.D.; M. B. Dahlke, M.D.; W. T. London, M.D., F.A.C.P.; A. J. Sutnick, M.D., F.A.C.P.; B. S. Blumberg, M.D., F.A.C.P.; J. R. Senior, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
A means was sought to reduce the high incidence of hepatitis after blood transfusion in patients at Philadelphia General Hospital (PGH). This was prompted by the finding that the incidence at PGH was many times greater than in patients observed concurrently at the Hospital of the University of Pennsylvania (HUP). Beginning in January 1969 donor units of blood were tested by immunodiffusion for Australia antigen (Au(1)) at both hospitals, so that units positive for Au(1) could be excluded. Before donor unit testing we had previously observed at PGH 10 cases of hepatitis in 56 recipients in 1963 and 13 cases
Goeser E, Dahlke MB, London WT, et al. Reduced Hepatitis After Blood Transfusion by Australia Antigen Testing of Donor Blood.. Ann Intern Med. 1971;74:834. doi: https://doi.org/10.7326/0003-4819-74-5-834_4
Download citation file:
Published: Ann Intern Med. 1971;74(5):834.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use